Artelo Biosciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - Square Gate Capital Master Fund, LLC [Member]	1 Months Ended
	Jan. 30, 2026 USD ($) $ / shares shares
Equity purchase agreement description	the Company has the right, but not the obligation, to direct Square Gate to purchase up to $25 million (the “Initial Commitment Amount”) in shares of common stock, par value $0.001 per share, of the Company, which at the Company’s sole discretion can be increased by an additional $25 million once the Initial Commitment Amount has been exhausted, subject to the terms and conditions contained in the Purchase Agreement
Number of shares issued, shares \| shares	106,026
Aggregate value of shares and prefunded warrants \| $	$ 500,000
Legal fees \| $	$ 35,000
Number of warrants issued \| shares	186,372
Exercise price of warrants \| $ / shares	$ 0.001